Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedLocation information was updated: state locations (California, Massachusetts, Missouri, New York, Texas) were revised under Locations and the revision tag updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedMinor editorial updates to the Publications section text and the revision label (v3.2.0 to v3.3.2) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe funding-lapse notice has been removed from the page, and other study content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedNo additions or deletions were observed; the page content remains unchanged.SummaryDifference0.4%

- Check89 days agoChange DetectedCore update: new operating-status notice and a new version (v3.2.0) are added, replacing the previous v3.1.0.SummaryDifference2%

- Check96 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.